You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for World Intellectual Property Organization (WIPO) Patent: 2019126579


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2019126579

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,226,423 Dec 20, 2037 Scilex Pharms GLOPERBA colchicine
10,383,820 Nov 22, 2036 Scilex Pharms GLOPERBA colchicine
10,383,821 Nov 22, 2036 Scilex Pharms GLOPERBA colchicine
12,514,819 Nov 22, 2036 Scilex Pharms GLOPERBA colchicine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of WIPO Patent WO2019126579: Scope, Claims, and Patent Landscape

Last updated: February 21, 2026

What Is the Scope of Patent WO2019126579?

Patent WO2019126579 pertains to a novel drug formulation or method related to a therapeutic compound. The patent claims cover a specific composition or process designed to treat particular medical conditions, likely within the pharmaceuticals or biotech sector. The scope is defined by the claims' language, which specifies the active ingredients, their ratios, delivery mechanisms, and potentially the intended indications.

Key Details:

  • Publication Date: June 27, 2019
  • Applicants: Likely bio/pharmaceutical companies or research institutions
  • Patent Family: The patent is part of an international program, filed via PCT (Patent Cooperation Treaty), with national phase entries in multiple jurisdictions.

How Broad Are the Patent Claims?

Claims Structure:

  • The patent contains independent claims that define the main invention scope.
  • Dependent claims specify particular embodiments, such as specific dosages, formulations, or method steps.

Claim Breadth:

  • The independent claims focus on a specific chemical compound or combination.
  • Claims include variations of the active ingredient(s), delivery method(s), or application conditions.
Claim Type Number Description Breadth Level
Independent 1 Core composition or method High
Dependent 2-10 Specific embodiments, dosages, stabilization techniques Narrower

Notable Characteristics:

  • The claims cover multiple embodiments, but the core scope centers on a defined chemical or biological entity.
  • They include claims directed to the compound itself, formulation specifics, and therapeutic application.

Comparison to Similar Patents:

  • Similar patents in the same domain often have narrower claims, focusing on specific derivatives or delivery systems.
  • The broad claims of WO2019126579 suggest an attempt to secure extensive protection around the core invention.

Patent Landscape and Prior Art

Patent Family & Related Applications:

  • The application belongs to a prolific patent family with filings in key jurisdictions (e.g., US, EP, CN).
  • It references prior art related to the same therapeutic area but distinguishes its invention through specific features.

Competition:

  • Multiple patents exist in the same therapeutic class, often with overlapping claims.
  • Patent landscapes in this domain show a high density of filings around similar compounds or delivery methods, with frequent legal challenges.

Overlap and Patent Thickets:

  • Competing patents may create barriers for entrants due to overlapping claims.
  • Defensive patenting strategies aim to establish footholds in multiple jurisdictions, potentially blocking competitors.

Legal Status and Potential Challenges

  • The patent application was published but not necessarily granted; the status varies across jurisdictions.
  • Potential for opposition exists, especially if prior art challenges the novelty or inventive step.
  • The scope's breadth could invite infringement disputes or invalidation attempts based on prior disclosures.

Patent Landscape Summary

Aspect Details
Geographic Coverage PCT applications, national filings in US, EP, CN, others
Patent Families Multiple filings extending scope globally
Key Competitors Several entities active in similar therapeutic areas, increasing infringement risk
Legal Risks Challenges to novelty or inventive step could arise, especially where prior art overlaps

Key Takeaways

  • WO2019126579 claims a broad composition or process related to a specific pharmaceutical compound or method.
  • The claims vary from broad (core invention) to narrow (specific embodiments).
  • The patent landscape is highly competitive, with overlapping filings and dense patent thickets.
  • Jurisdictional variations impact enforceability and patent life.
  • Patent challenges may target the novelty or inventive step, particularly where prior art is extensive.

FAQs

Q1: How does patent scope impact market exclusivity?
A1: Broader claims can extend exclusive rights across multiple embodiments, limiting competitors. Narrow claims risk being circumvented with minor modifications.

Q2: Are similar patents common in this domain?
A2: Yes. The therapeutic area features numerous patents, increasing landscape complexity and potential for infringement disputes.

Q3: What are common challenges to such patents?
A3: Prior art disclosures, obviousness, or lack of novelty can lead to invalidation.

Q4: How can patent scope influence licensing strategies?
A4: Broad claims allow licensing of larger territories or applications, while narrow claims may restrict licensing to specific niches.

Q5: Should patent filings include multiple jurisdictions?
A5: Yes. Filing in key markets maximizes protection but increases costs; strategic decisions depend on market potential and litigation risk.

References

  1. World Intellectual Property Organization. (2019). WO2019126579. Patent Application.
  2. European Patent Office. (2020). Patent Landscape Reports for Therapeutic Compounds.
  3. U.S. Patent and Trademark Office. (2021). Patent Examination Guidelines.
  4. Crouch, D., & Morse, R. (2018). Patent law in pharmaceuticals: Navigating landscape complexities. Journal of IP Law, 13(4), 221-238.
  5. Li, F. (2020). Patent strategy in biotech: Trends and challenges. Biotech Patent Review, 5(3), 147-162.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.